Baxter Healthcare S.A. /dba Baxter

Form 483 issued February 6, 2015 · Guayama, Puerto Rico

Inspection
Jan 21 – Feb 6, 2015
Investigator
Libia M. Lugo
Observations
2
Pages
3
FEI number
2650090

In short: On February 6, 2015, FDA issued a Form 483 with 2 observations to Baxter Healthcare S.A. /dba Baxter in Guayama, Puerto Rico (FEI 2650090) after an inspection that ran Jan 21 – Feb 6, 2015. The investigator was Libia M. Lugo. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

2 of 2 observations on this 483 concern quality system.

Quality system2

Most cited: 21 CFR 211.22(d) (1×) · 211.192 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Written records of investigations into unexplained discrepancies do not always include…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Baxter Healthcare S.A. /dba Baxter?

FDA listed 2 observations on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Baxter Healthcare S.A. /dba Baxter?

Libia M. Lugo is named on this Form 483, for the inspection of Jan 21 – Feb 6, 2015. Each investigator has a profile showing what they cite most.

When was Baxter Healthcare S.A. /dba Baxter inspected by FDA?

The inspection ran Jan 21 – Feb 6, 2015, and the Form 483 is dated February 6, 2015.

How do I get the full Form 483 for Baxter Healthcare S.A. /dba Baxter?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free